Multinational Biopharmaceutical Development Corporation – Big Pharma
GSK was interested in promoting third-party sales for its large portfolio of manufacturing assets around the world. North American and European trade shows provided a valuable platform for GSK’s sales teams to create additional revenue streams by licensing embedded CDMO service capacity as it became available.